Jove
Visualize
联系我们

相关概念视频

The Placebo Effect01:54

The Placebo Effect

6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Blind Procedures02:07

Blind Procedures

12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Blinding01:11

Blinding

3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Classical Conditioning in Daily Life01:17

Classical Conditioning in Daily Life

2.0K
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
2.0K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predicting placebo analgesia responses in clinical trials: where to look next? A meta-analysis of individual patient data.

Pain·2025
Same author

Visualizing Neighborhood COVID-19 Levels, Trends, and Inequities in Wastewater: An Equity-Centered Approach and Comparison to CDC Methods.

Journal of public health management and practice : JPHMP·2024
Same author

Implementation of Neighborhood-Level Wastewater-Based Epidemiology to Measure and Mitigate Inequities in SARS-CoV-2 Infection in Boston, Massachusetts.

American journal of public health·2024
Same author

Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.

The New England journal of medicine·2023
Same author

Do Polymorphisms Predict Hypnotherapy Response in Children With Functional Abdominal Pain Disorders: An Explorative Study.

Journal of pediatric gastroenterology and nutrition·2023
Same author

Open notes: Unintended consequences and teachable moments.

Journal of medical ethics·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 13, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.7K

代替的树木.

Henry K Philofsky1, Isaac Mukamal2, Kathryn T Hall3

  • 1Department of Psychiatry, University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, United States.

Handbook of clinical neurology
|October 29, 2025
PubMed
概括
此摘要是机器生成的。

"地方组"中的遗传变异可能会混随机临床试验 (RCT) 的结果. 药物和安慰剂臂之间的不同遗传效应可以掩盖真正的治疗疗效.

关键词:
临床研究是临床研究.药物开发 药物开发遗传学 遗传学 是一个基因组学就是基因组学.避孕药是一种安慰剂.避孕药遗传学 避孕药遗传学

更多相关视频

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

23.3K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.6K

相关实验视频

Last Updated: Jan 13, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.7K
Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

23.3K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.6K

科学领域:

  • 药物遗传学 药物遗传学
  • 临床试验方法论 临床试验方法论
  • 遗传学和个性化医学

背景情况:

  • 随机临床试验 (RCT) 使用安慰剂来控制影响结果的非特定因素,统称为"安慰剂反应".
  • 随机试验的核心假设是安慰剂和药物反应的附加性,药物的疗效计算为它们之间的差异.
  • 已知遗传变异会影响安慰剂效应和疾病自然史,这是安慰剂反应的关键组成部分.

研究的目的:

  • 审查关于"安慰剂组" (安慰剂反应的调解者) 内的遗传变异如何影响RCT结果的证据.
  • 探索基因与药物/安慰剂相互作用的潜力,以混治疗效果估计.
  • 突出遗传影响对安慰剂反应对临床试验设计和解释的影响.

主要方法:

  • 关于对安慰剂反应组件的遗传影响现有证据的文献综述.
  • 分析遗传变异可能如何差异影响RCT药物与安慰剂臂的结果.
  • 检查" placebobome"的概念及其在调解安慰剂效应中的作用.

主要成果:

  • 遗传变异可以影响安慰剂效应和疾病的自然史,有助于整体安慰剂反应.
  • 人们对遗传变异如何调节可以改变安慰剂效应的药物 (如纳洛) 的作用知之甚少.
  • 治疗臂之间的不同遗传影响可能导致基因与药物/安慰剂相互作用,可能掩盖真正的药物疗效.

结论:

  • 假药组中的遗传变异可能是RCT中混的潜在来源.
  • 了解这些遗传影响对于准确解释药物疗效至关重要.
  • 未来的研究应该调查基因与药物/安慰剂相互作用,以完善临床试验方法.